Advertisement
Screener

Dyne Therapeutics, Inc. (DYN) ROA

Dyne Therapeutics, Inc. (DYN) ROA

  • 2026-06-30: ROA -52.25%.
  • 2026-03-31: ROA -41.83%.
  • 2025-12-31: ROA -37.59%.
  • 2025-09-30: ROA -48.88%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-52.25%
2026-03-31-41.83%
2025-12-31-37.59%
2025-09-30-48.88%
2025-06-30-56.64%
2025-03-31-50.91%
2024-12-31-45.92%
2024-09-30-38.31%
2024-06-30-31.19%
2024-03-31-49.28%
2023-12-31-142.92%
2023-09-30-101.40%
2023-06-30-75.29%
2023-03-31-61.22%
2022-12-31-54.88%
2022-09-30-60.42%
2022-06-30-53.60%
2022-03-31-41.24%
2021-12-31-35.07%
2021-09-30-27.02%
2021-06-30-20.87%
2021-03-31-15.56%
2020-12-31-16.82%
2020-09-30-9.49%
2019-12-31-90.40%

Annual ROA

DateROA
2025-12-31-37.59%
2024-12-31-45.92%
2023-12-31-142.92%
2022-12-31-54.88%
2021-12-31-35.07%
2020-12-31-16.82%
2019-12-31-90.41%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Disc Medicine, Inc. (IRON)United States$2.553B-11.40